IRIS
LASAGNA, ANGIOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.423
AS - Asia 1.048
EU - Europa 811
SA - Sud America 176
AF - Africa 92
OC - Oceania 2
Totale 3.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.381
SG - Singapore 319
CN - Cina 271
IT - Italia 194
HK - Hong Kong 150
VN - Vietnam 139
RU - Federazione Russa 135
BR - Brasile 120
DE - Germania 103
IE - Irlanda 99
FI - Finlandia 72
FR - Francia 62
ZA - Sudafrica 60
IN - India 46
GB - Regno Unito 45
BD - Bangladesh 22
CA - Canada 21
AR - Argentina 17
JP - Giappone 17
TR - Turchia 15
ES - Italia 14
PL - Polonia 13
AT - Austria 11
VE - Venezuela 11
SE - Svezia 10
IQ - Iraq 9
CO - Colombia 8
MA - Marocco 8
NL - Olanda 8
PK - Pakistan 8
EC - Ecuador 7
TN - Tunisia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
PH - Filippine 6
LT - Lituania 5
MX - Messico 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
ID - Indonesia 4
JM - Giamaica 4
UA - Ucraina 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
DM - Dominica 2
IL - Israele 2
JO - Giordania 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
YT - Mayotte 1
Totale 3.552
Salva come PNG Salva come JPEG
Città #
San Jose 225
Dallas 178
Singapore 169
Hong Kong 147
Ashburn 136
Chandler 97
Dublin 95
Beijing 88
New York 75
Ho Chi Minh City 59
Johannesburg 53
Munich 53
Boardman 50
Lauterbourg 45
Council Bluffs 42
Helsinki 42
Los Angeles 39
Hanoi 32
Shanghai 32
Turku 30
Milan 28
Moscow 22
Redondo Beach 22
Orem 19
Seattle 19
Buffalo 17
São Paulo 17
Rome 16
Pescara 15
Santa Clara 15
Pavia 14
Princeton 14
Chennai 13
Lawrence 13
Tokyo 13
Frankfurt am Main 12
Medford 12
Montreal 11
Warsaw 11
Brooklyn 10
Denver 10
Stockholm 10
The Dalles 10
San Francisco 9
Baghdad 8
Düsseldorf 8
Guangzhou 8
Atlanta 7
Cagliari 7
Nuremberg 7
Vienna 7
Biên Hòa 6
Da Nang 6
Poplar 6
Toronto 6
Wilmington 6
Boston 5
Columbus 5
Delhi 5
Falkenstein 5
Houston 5
Manchester 5
Porto Alegre 5
Tashkent 5
Amsterdam 4
Ankara 4
Bergamo 4
Buenos Aires 4
Casablanca 4
Dhaka 4
Hangzhou 4
London 4
Washington 4
Baku 3
Belo Horizonte 3
Bogotá 3
Brussels 3
Cairo 3
Charlotte 3
Desio 3
Fortaleza 3
Ha Long 3
Hyderabad 3
Istanbul 3
Lima 3
Luanda 3
Mexico City 3
Nairobi 3
New Delhi 3
Prague 3
Quito 3
Reggio Emilia 3
Rio de Janeiro 3
Tangier 3
Alghero 2
Amman 2
Ann Arbor 2
Bengaluru 2
Betim 2
Biassono 2
Totale 2.272
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 157
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 148
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 130
Torque teno virus and cancers: current knowledge 127
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 118
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature 110
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 109
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 104
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 103
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 102
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 101
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life 96
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 94
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 93
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 92
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 92
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 90
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 88
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? 84
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 82
How to use prophylactic G-CSF in the time of COVID-19 78
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 75
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 75
Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey 74
Infectious complications and immunotherapy: old pitfalls and new horizons 74
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy 74
The 'hit-and-run' strategy and viral carcinogenesis 69
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 69
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 69
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 69
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 69
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 68
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review 66
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink 65
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features 64
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 64
The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature 63
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) 61
COVID-19 and breast cancer: May the microbiome be the issue? 61
Reply to Y. Ergun et al 60
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 44
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma 41
Postvaccination immune-mediated hepatitis: what do we really know? 34
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View 8
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness 7
Totale 3.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202284 6 0 1 0 4 1 10 5 2 11 7 37
2022/2023285 22 29 4 26 21 13 0 10 114 2 40 4
2023/2024350 41 51 14 22 29 85 24 31 0 11 14 28
2024/2025834 26 40 45 9 11 60 54 50 186 48 109 196
2025/20262.053 133 113 218 229 251 97 349 125 201 155 130 52
Totale 3.621